Artificial intelligence for gastric cancer in endoscopy: From diagnostic reasoning to market
- PMID: 38763796
- DOI: 10.1016/j.dld.2024.04.019
Artificial intelligence for gastric cancer in endoscopy: From diagnostic reasoning to market
Abstract
Recognition of gastric conditions during endoscopy exams, including gastric cancer, usually requires specialized training and a long learning curve. Besides that, the interobserver variability is frequently high due to the different morphological characteristics of the lesions and grades of mucosal inflammation. In this sense, artificial intelligence tools based on deep learning models have been developed to support physicians to detect, classify, and predict gastric lesions more efficiently. Even though a growing number of studies exists in the literature, there are multiple challenges to bring a model to practice in this field, such as the need for more robust validation studies and regulatory hurdles. Therefore, the aim of this review is to provide a comprehensive assessment of the current use of artificial intelligence applied to endoscopic imaging to evaluate gastric precancerous and cancerous lesions and the barriers to widespread implementation of this technology in clinical routine.
Keywords: Artificial intelligence; Clinical reasoning; Deep learning; Endoscopy; Gastric cancer; Gastric intestinal metaplasia; Gastrointestinal.
Copyright © 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest COM has full-time employment in AI Medical Service America Inc. TT is the CEO of AI Medical Service Inc. JLB is Consultant for Boston Scientific Corporation, Cook Medical LLC, and Olympus America Inc.; travel compensation and food and beverage compensation from Boston Scientific Corporation. KO is an advisory member of AI Medical Service Inc. The other authors declare no conflict of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
